dengue

Dengue continues to be a threat to global and national health. With the threat of global warming, more countries will be at risk for dengue. Dengue is endemic in the Philippines, with cases reported since the 1950s. In an effort to address this problem, ICHHD has several ongoing studies related to dengue.

As vector control was the only means of prevention, newer modalities are necessary for dengue prevention. The World Health Organization (WHO) identified several research questions that need to be answered when the dengue vaccine was used in the community. Due to the complex nature of dengue disease, epidemiology, and pathogenesis, it is important to closely monitor how the vaccine performs outside of the clinical trial setting. In 2017, the Dengue Serostatus Study was initiated with funding from the Hanako Foundation, the WHO, and the Philippine Department of Health.

    1. Persistent pulmonary hypertension of the newborn (Link)

    2. Combined analysis of prenatal (maternal hair and blood) and neonatal (infant hair, cord blood and meconium) matrices to detect fetal exposure to environmental pesticides (Link)

    3. An epidemiologic study comparing fetal exposure to tobacco smoke in three Southeast Asian countries (Link)

    4. Use of the Griffiths Mental Development Scales in an argo-industrial province in the Philippines (Link)

    5. Fetal exposure to propoxur and abnormal child neurodevelopment at 2 years of age (Link)

    6. Analysis of house dust and children’s hair for pesticides: A comparison of markers on ongoing pesticide exposure in children (Link)

    7. Trends in long-term exposure to propoxur and pyrethroids in young children in the Philippines (Link)

Study Partners